New Advancements in Cancer Detection and Treatment
Title
:
New Advancements in Cancer Detection and Treatment
Description
:
Leading Expert and Cancer Survivor Patient on How Biotechnology is Saving Lives
There are more than 12 million cancer survivors living in the U.S. today and many of them can thank biotechnology therapies for saving their lives. Encouraging progress is being made daily in attacking this challenging and life-threatening disease, as the U.S. marks Breast Cancer Awareness Month (Oct.).
Today’s biotechnology therapies are more targeted, more personalized, and often produce fewer side effects than traditional treatments. Gene testing allows for better detection and more targeted treatments. Cancer vaccines are preventing infections from cancer-causing viruses as well as treating existing cancers, without harming healthy cells. As the country’s aging population increases, these new therapies are rising to the challenge of eradicating this disease, which will kill nearly 566,000 Americans this year.
James C. Greenwood, President and CEO of the Biotechnology Industry Organization
Jim Greenwood is President and CEO of the Biotechnology Industry Organization (BIO) in Washington, D.C., which represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. Mr. Greenwood represented Pennsylvania's Eighth District in the U.S. House of Representatives from 1993 to 2005. A senior member of the Energy and Commerce Committee, he was widely viewed as an expert on health and the environment
Lori Lober, Breast Cancer Survivor
In 2000, Lori Lober was diagnosed with stage IV breast cancer, which had spread to her lymph nodes and to her liver. The standard treatment for her type of cancer offered no hope, and her physician said she had 12-18 months to live. Lori opted to participate in a clinical trial offering a biotechnology treatment. By using this as the foundation of her treatment, and combining other therapies, she is alive and well today. Through her book, “Bigger than Pink,” and her foundation, “Touched by Cancer,” Lober has become an unwavering beacon of hope for those who have been affected by cancer firsthand or through a loved one's experience. .
Date
:
Oct. 07, 2008
Credit
:
Video: Produced for Biotechnology Industry Organization
Interviews:
James C. Greenwood, President and CEO of the Biotechnology Industry Organization
Lori Lober, Breast Cancer Survivor
Flash Conversion and Editing: Scientific Frontline
The
Images and Video's in the gallery pages may be protected by
copyright. You may download one copy for non-commercial personal
use to be displayed on your personal computer. Use other then
non-commercial requires that you obtain permission if
copyrighted from the copyright holder. See disclaimer page for
more detail. We will help direct you to the proper source if you
are unsure of copyright holder or your usage. Please always state
proper source / credit.
